October 2026
1. BHUTTA ZA, Ahn D, Lee HK, Choi KC, et al
   Evaluation of Punicalagin as a multi?targeted therapeutic agent against endometrial cancer.
   Int J Oncol. 2026;69:109.
   

   >> Share

   
   July 2026
2. PEI CZ, Song XX, Xu H, Baek KH, et al
   Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review).
   Int J Oncol. 2026;69:79.
   

   >> Share

   
   May 2026
3. KIM A, Kim J, Kwak W, Mo K, et al
   Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
   Int J Oncol. 2026;68:57.
   

   >> Share

   
   
4. LIU R, Martin TA, Jordan NJ, Ruge F, et al
   [Corrigendum] Epithelial protein lost in neoplasm?alpha (EPLIN?alpha) is a potential prognostic marker for the progression of epithelial ovarian cancer.
   Int J Oncol. 2026;68:61.
   

   >> Share

   
   April 2026
5. MUKINOVIC E, Federmann S, Messling L, Sekeres M, et al
   Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil?mediated promotion of DNA damage?driven cytotoxicity.
   Int J Oncol. 2026;68:48.
   

   >> Share

   
   February 2026
6. WANG F, Xu X, Guan B, Li X, et al
   Regulation and reversal of paclitaxel resistance via the STAT1?mediated apoptotic pathway in ovarian cancer.
   Int J Oncol. 2026;68:19.
   

   >> Share

   
   
7. YE H, Zhang Y, Geng L, Li Z, et al
   [Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration.
   Int J Oncol. 2026;68:20.
   

   >> Share

   
   August 2025
8. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
   RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
   Int J Oncol. 2025;67:65.
   

   >> Share

   
   
9. LIU R, Martin TA, Jordan NJ, Ruge F, et al
   [Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
   Int J Oncol. 2025;67:64.
   

   >> Share

   
   December 2024
10. LIU Y, Xiao H, Zeng H, Xiang Y, et al
    Beyond tumor?associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review).
    Int J Oncol. 2024;65:117.
    

    >> Share

    
    November 2024
11. ZHU Y, Yang W, Wang X, Chen M, et al
    AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer.
    Int J Oncol. 2024;65:107.
    

    >> Share

    
    
12. TAN H, He Q, Gong G, Wang Y, et al
    [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Int J Oncol. 2024;65:110.
    

    >> Share

    
    October 2024
13. SUN J, Chu H, Ji J, Huo G, et al
    [Retracted] Long non?coding RNA HOTAIR modulates HLA?G expression by absorbing miR?148a in human cervical cancer.
    Int J Oncol. 2024;65:97.
    

    >> Share

    
    August 2024
14. XU S, Zhu C, Xu Q, An Z, et al
    ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway.
    Int J Oncol. 2024;65:76.
    

    >> Share

    
    June 2024
15. FU M, Deng F, Chen J, Fu L, et al
    Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Int J Oncol. 2024;64:62.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share